Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul Montserrat is active.

Publication


Featured researches published by Paul Montserrat.


Circulation | 1992

Elimination of atrioventricular nodal reentrant tachycardia using discrete slow potentials to guide application of radiofrequency energy

M. Haissaguerre; F Gaita; Bruno Fischer; D Commenges; Paul Montserrat; C d'Ivernois; P Lemetayer; J. F. Warin

BackgroundAblation of the slow pathway has been performed to eliminate atrioventricular (AV) nodal reentrant tachycardia (AVNRT) either by a surgical approach or by using radiofrequency catheter technique guided by retrograde slow pathway activation mapping. From previous experience of midseptal and posteroseptal mapping, we were aware of the existence of peculiar slow potentials in most humans. Postulating their role in AVNRT, we studied these potentials and the effects of radiofrequency energy. Methods and ResultsSixty-four patients (mean age, 48±19 years) with the usual form ofAVNRT were studied. Slow, low-amplitude potentials were recorded when using the anterograde AV conducting system. Slow potentials occupied all (giving a continuum of electrograms) or some of the time between the atrial and ventricular electrograms. Their most specific patterns were their progressive response to increasing atrial rates, which resulted in a dramatic decline in amplitude and slope, a corresponding increase in duration, and a separation from preceding atrial potentials until the disappearance of any consistent activity. Slow potentials were recorded along a vertical band at the mid or posterior part of the septum near the tricuspid annulus. Radiofrequency energy applied at the slow potential site resulted in interruption of induced tachycardia within a few seconds and rendered tachycardia noninducible in all patients. A median of two impulses was delivered to each patient. In 69% of patients, postablation atrial stimulation cannot achieve a long atrial-His interval, which previously was critical for tachycardia induction or maintenance. No patient had AVNRT over a follow-up period of 1-16 months, and all had preserved AV conduction. In all except two patients, the PR interval was unchanged. In 47 patients, long-term electrophysiological studies confirmed the efficacy of ablation and the nonreversibility of results by isoproterenol; however, echo beats remained inducible in 40%1 of patients. ConclusionsAn area showing slow potentials is present at the perinodal region in humans. In patients with AVNRT, application of radiofrequency energy renders tachycardia noninducible through the preferential modification of the anterograde slow pathway. With present clinical methods, the exact origin and significance of these physiological potentials cannot be specified.


American Journal of Cardiology | 1992

Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathways

Michel Haïssaguerre; Bruno Fischer; Thierry Labbé; P Lemetayer; Paul Montserrat; Christophe D'ivernois; Jean-François Dartigues; J. F. Warin

The effect of successful catheter ablation of overt accessory pathways on the incidence of atrial fibrillation (AF) was studied in 129 symptomatic patients with (n = 75) or without (n = 54) previous documented AF. Fourteen had had ventricular fibrillation. Factors predictive of recurrence were examined, including electrophysiologic parameters. Atrial vulnerability was defined as induction of sustained AF (greater than 1 minute) using single, then double, atrial extrastimuli at 2 basic pacing cycle lengths. When compared to patients with only reciprocating tachycardia, patients with clinical AF included more men (77 vs 54%, p = 0.008) and were older (35 +/- 12 vs 29 +/- 12 years, p = 0.01). They had a significantly shorter cycle length leading to anterograde accessory pathway block (252 +/- 42 vs 298 +/- 83 ms, p less than 0.001), greater incidences of atrial vulnerability (89 vs 24%, p less than 0.001) and subsequent need for cardioversion (51 vs 15%, p less than 0.001). After discharge, the follow-up period was 35 +/- 12 months (range 18 to 76); 7 patients with previous spontaneous AF (9%) had recurrence at a mean of 10 months after ablation. Age, presence of structural heart disease accessory pathway location, atrial refractory periods and accessory pathway anterograde conduction parameters were not predictive of AF recurrence. Persistence of atrial vulnerability after ablation was the only factor associated with further recurrence of AF. Atrial vulnerability was observed after ablation in only 56% of patients with previous AF versus 89% before ablation. It is concluded that successful catheter ablation of accessory pathways prevents further recurrence of AF in 91% of patients.(ABSTRACT TRUNCATED AT 250 WORDS)


Pacing and Clinical Electrophysiology | 1990

Catheter Ablation of Accessory Pathways: Technique and Results in 248 Patients

J. F. Warin; Michel Haïssaguerre; Christophe D'ivernois; Philippe Le Métayer; Paul Montserrat

WARIN, J.‐F., ET AL.: Catheter Ablation of Accessory Pathways: Technique and Results in 248 Patients. Two hundred and forty‐eight patients with refractory arrhythmias related to an accessory pathway underwent catheter ablation. Cathodal shocks (I60 to 240 joules) were delivered through the distal electrode of a standard catheter (usually a quadripolar electrode catheter with 5‐mm interelectrode distances). A paddle electrode positioned opposite to the catheter served as the anode. Ablation of 24 right anteroseptal, 16 right parietal, 86 posteroseptal, 120 left parietal and four Mahaim pathways was clinically successful in eliminating symptomatic tachycardia in 236 patients (>96%) over a follow‐up of 3 to 64 months. There was no procedure‐related death but two patients developed a ventricular fibrillation at the fifth and seventh day, respectively. The latter led to a sudden death since this side effect occurred after discharge. There were no instances of systemic embolus but one pericardial effusion required subxiphoid needle drainage 6 weeks after the procedure. Other complications included: AV block in four patients with posteroseptal and in one with a right anterior septal pathway. In conclusion, a successful clinical outcome may be achieved in most patients. Catheter ablation is an important alternative to cardiac surgery and in our opinion represents first‐line treatment when therapy is required.


Circulation | 1990

Catheter ablation of Mahaim fibers with preservation of atrioventricular nodal conduction.

M. Haissaguerre; J. F. Warin; P Le Metayer; L. Maraud; L De Roy; Paul Montserrat; J. P. Massiere

Three patients with refractory preexcited tachycardia implicating Mahaim fibers underwent attempted catheter ablation of the accessory pathway. In the absence of demonstrable retrograde conduction in Mahaim fibers, we located the accessory pathway ventricular insertion site using the criteria of concordance between paced and spontaneous QRS morphologies during pace-mapping and earliest onset of local electrogram relative to surface preexcited QRS. At this site, a QS-like pattern of unfiltered unipolar electrograms with steep downstroke was recorded. The optimal site appeared radiologically at the right ventricular anterior wall or the adjacent septum, 2-4 cm from the tricuspid anulus. Three to six 160-J shocks were delivered at this site using an anterior chest wall plate as anode. After fulguration, conduction through the Mahaim tract was absent. A right bundle branch block persisted in two patients. All patients remained free of preexcited tachycardia during 12-16 months of follow-up. Postablation electrophysiological assessment showed no preexcitation in any patient. No reciprocating tachycardia was inducible, even during isoproterenol infusion. Atrioventricular nodal conduction parameters were unchanged from baseline study. Catheter ablation of Mahaim fibers is an effective alternative method for the treatment of tachycardias that include the accessory pathway in the circuit.


Pacing and Clinical Electrophysiology | 1990

Distinctive response of arrhythmogenic right ventricular disease to high dose isoproterenol.

M. Haissaguerre; P.H. Le Métayer; Christophe D'ivernois; Paul Montserrat; J. F. Warin; J.L. Barat

HAISSAGUERRE, M., ET AL.: Distinctive Response of Arrhythmogenic Right Ventricular Disease to High Dose Isoproterenol.Arrhythmogenic right ventricular disease is a potential cause of ventricular arrhythmias. Diagnosis is important due to the risk of sudden death, particularly as first symptom. Diagnosis is based on the angiographic demonstration of abnormal right ventricular morphology and function, while the sensitivity of noninvasive tests is relatively low. Following a particular observation studied in 1984, we prospectively assessed the diagnostic value of high dose isoproterenol infusion in 44 patients with an angiographically determined arrhythmogenic right ventricle. A continuous infusion of isoproterenol (8–30 µg/min) was administered during a 3‐minute period, regardless of the obtained heart rate. In a control group of 50 patients without structural heart disease, isoproterenol induced a monomorphic ventricular tachycardia salvo in only one patient (2%). In patients with an arrhythmogenic right ventricle, isoproterenol induced one or more ventricular tachycardia runs in 39/44 cases (88%): one triplet in three patients, several runs in 23 patients and a sustained ventricular tachycardia in 13 patients. Arrhythmia was polymorphous in 85% of cases, but left bundle branch block morphelogy was the predominant pattern. In conclusion, high dose isoproterenol is a highly sensitive test for the diagnosis of arrhythmogenic right ventricular disease.


American Journal of Cardiology | 1998

Usefulness of Isometric Exercise During Dobutamine Administration for Stress Echocardiography

Christophe Chauvel; E. Bogino; Pascal Reynaud; Bruno Fischer; Paul Montserrat; Nicolas Sourdille; Patrick Dehant

An isometric exercise was performed by 170 consecutive patients at peak dose dobutamine, before atropine administration. The test was well tolerated, heart rate increased significantly during exercise, and atropine administration was avoided in 29% of patients.


Pacing and Clinical Electrophysiology | 1990

Fulguration for AV Nodal Tachycardia: Results in 42 Patients with a Mean Follow‐Up of 23 Months

M. Haissaguerre; J. F. Warin; Christophe D'ivernois; P.H. Le Métayer; Paul Montserrat

HAISAGUERRE, M., ET AL.: Fulguration for AV Nodal Tachycardia: Results in 42 Patients with a Mean Follow‐Up of 23 Months. This report describes a catheter ablation technique to treat atrioventricular nodal reentrant tachycardia while preserving anterograde conduction, and its application in 42 patients with drug‐refractory repetitive episodes of tachycardia. One of these patients had common and reverse forms of tachycardia. Using atrial activation in the His‐bundle lead as a reference, the optimal ablation site was selected by positioning an electrode catheter to obtain a synchronous or earlier atrial activation than the reference during tachycardia. At this site, His‐bundle deflection was completely absent, or was present at a low amplitude (< 0.1 mV). In the majority of patients, these criteria were found in the immediate vicinity of the site of proximal His‐bundle recording (adjacent to the reference catheter). Shocks of 160 or 240 joules (J) were delivered at this site (mean ± SD = 518 ± 392 J/session) with a resulting preferential abolition of impairment of fast retrograde conduction. Anterograde conduction, though modified, was preserved in all patients, except for four (10%) patients who remained in complete heart block. Thirty patients (70%) remained free of arrhythmia without medication or pacemaker for a mean follow‐up period of 23 ± 13 (2–63) months. Six other patients (15%) were controlled with a previously ineffective medication.


Archive | 1995

Cardiac surgery in octogenarians: Perioperative results and clinical follow-up

Francis Fontan; Alain Becat; Guy Fernandez; Nicolas Sourdille; Pascal Reynaud; Paul Montserrat

Due to increased life expectancy, particularly in Western societies, the cardiac surgeon is confronted more and more often with decisions as to the indication or contraindication of an operation for increasingly older patients. Although advanced age is recognized as a risk factor for death, favourable results have been reported after CABG in patients over 75 and after aortic valve replacement in octogenarians [1-4].


European Heart Journal | 1991

Catheter ablation of left posteroseptal accessory pathways and of long RP′ tachycardias with a right endocardial approach

M. Haissaguerre; Paul Montserrat; J. F. Warin; J. P. Donzeau; P. Le Metayer; J. P. Massiere


Journal of Interventional Cardiology | 1990

Catheter Ablation of Left Parietal Accessory Pathways

J. F. Warin; Michel Haïssaguerre; Philippe Le Métayer; Paul Montserrat; Jean‐Paul Massière

Collaboration


Dive into the Paul Montserrat's collaboration.

Top Co-Authors

Avatar

J. F. Warin

University of Bordeaux

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

P Lemetayer

University of Bordeaux

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Francis Fontan

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar

Guy Fernandez

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge